Structure-function studies of human interferons-alpha: enhanced activity on human and murine cells.
To identify functionally important regions of the human interferon (IFN)-alpha molecule, mutagenesis in vitro of human IFN-a genes was used to create analogs with deletions or specific amino acid replacements. These analogs were expressed in vitro using SP6 RNA polymerase and a rabbit reticulocyte lysate protein synthesis system. Deletion of 7 highly conserved hydrophilic amino acids from the C-terminus of human IFN-alpha 4 reduced, but did not abolish, antiviral activity on human cells. However, analogs with deletions of 15 or 25 amino acids from the C-terminus, or 28 amino acids from the N-terminus, had no measurable antiviral activity. The antiviral activity of human IFN-alpha 4 was increased by substitution of cysteine for serine at position 86, and lysine for arginine at position 121. However, other amino acid substitutions at positions 121, 122 or 123 reduced antiviral activity. The size of the side chain of the amino acid residue at position 130 was shown to be important. Replacement of the absolutely conserved leucine residue at position 131 with glutamine had little effect on antiviral activity. However, the introduction of a proline residue at this position abolished antiviral activity, probably due to the formation of a beta turn in the polypeptide chain. The antiviral activity of human IFN-alpha 4 on murine cells was increased by substitutions at positions 86, 121 and 133. This study illustrates the utility of the in vitro mutagenesis and rabbit reticulocyte lysate systems for the investigation of structure-function relationships, and extends our knowledge of the biologically active regions and species specificity of the human IFN-alpha molecule.
Cheetham
B F
BF
Centre for Molecular Biology and Medicine, Monash University, Clayton, Victoria, Australia.
McInnes
B
B
Mantamadiotis
T
T
Murray
P J
PJ
Alin
P
P
Bourke
P
P
Linnane
A W
AW
Tymms
M J
MJ
D000818:Animals; D002417:Cattle; D002478:Cells, Cultured; D003545:Cysteine / Q000235:genetics; D006801:Humans; D066298:In Vitro Techniques; D007370:Interferon Type I / Q000737:chemistry / Q000235:genetics*; D016297:Mutagenesis, Site-Directed; D011817:Rabbits; D012156:Reticulocytes / Q000378:metabolism; D012694:Serine / Q000235:genetics; D013329:Structure-Activity Relationship
D007370:Interferon Type I; D012694:Serine; D003545:Cysteine